Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianjun Luo

Showing results (131-140 of 204) with videos related to

Pageof 21
Sort By:
European Journal of Gastroenterology & Hepatology|August 4, 2020
PTFE-covered TIPS is an effective treatment for secondary preventing variceal rebleeding in cirrhotic patients with high risksYongjie Zhou, Wen Zhang, Zihan Zhang, et al.
Abdominal Radiology (New York)|November 23, 2023
Endovascular management of sinistral portal hypertension-related variceal hemorrhage: a multicenter retrospective studyZhiquan Zhuang, Jingqin Ma, Zihan Zhang, et al.
Oncotarget|July 10, 2015
Transcriptome profiling of esophageal squamous cell carcinoma reveals a long noncoding RNA acting as a tumor suppressorGuifeng Wei, Huaxia Luo, Yu Sun, et al.
Brachytherapy|July 2, 2016
A pilot study of intraluminal brachytherapy using <sup>125</sup>I seed strand for locally advanced pancreatic ductal adenocarcinoma with obstructive jaundiceMinJie Yang, ZhiPing Yan, JianJun Luo, et al.
Disease Markers|September 23, 2022
Development of a Costimulatory Molecule Signature to Predict Prognosis, Immune Landscape, and Response to Immune Therapy for Hepatocellular CarcinomaYongjie Zhou, Xin Zhou, Qingxin Liu, et al.
BMC Gastroenterology|April 11, 2025
Correlation and consistency analysis between various indirect portal pressure gradients and actual portal pressure gradientRufeng Chen, Yaozu Liu, Li Ma, et al.
Frontiers in Immunology|January 27, 2023
Microwave ablation and synchronous transarterial chemoembolization combined with PD-1 inhibitor in patients with hepatocellular carcinoma following tyrosine kinase inhibitor intoleranceQin Shi, Xin Zhou, Zihan Zhang, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|March 22, 2022
A new alternative technique for the guidance of transjugular intrahepatic portosystemic shunt creation using DSA overlay referenceZhiquan Zhuang, Jingqin Ma, Shuai Ju, et al.
Abdominal Radiology (New York)|June 20, 2024
Unveiling the impact of cirrhotic cardiomyopathy on portal hemodynamics and survival after transjugular intrahepatic portosystemic shunt: a prospective studyYaozu Liu, Fangmin Meng, Jingqin Ma, et al.
Journal of Cancer Research and Clinical Oncology|December 31, 2013
Transarterial chemoembolisation (TACE) combined with endovascular implantation of an iodine-125 seed strand for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis versus TACE alone: a two-arm, randomised clinical trialMinjie Yang, Zhuting Fang, Zhiping Yan, et al.
Pageof 21

Showing results (131-140 of 204) with videos related to

Sort By:
Pageof 21
European Journal of Gastroenterology & Hepatology|August 4, 2020
PTFE-covered TIPS is an effective treatment for secondary preventing variceal rebleeding in cirrhotic patients with high risksYongjie Zhou, Wen Zhang, Zihan Zhang, et al.
Abdominal Radiology (New York)|November 23, 2023
Endovascular management of sinistral portal hypertension-related variceal hemorrhage: a multicenter retrospective studyZhiquan Zhuang, Jingqin Ma, Zihan Zhang, et al.
Oncotarget|July 10, 2015
Transcriptome profiling of esophageal squamous cell carcinoma reveals a long noncoding RNA acting as a tumor suppressorGuifeng Wei, Huaxia Luo, Yu Sun, et al.
Brachytherapy|July 2, 2016
A pilot study of intraluminal brachytherapy using <sup>125</sup>I seed strand for locally advanced pancreatic ductal adenocarcinoma with obstructive jaundiceMinJie Yang, ZhiPing Yan, JianJun Luo, et al.
Disease Markers|September 23, 2022
Development of a Costimulatory Molecule Signature to Predict Prognosis, Immune Landscape, and Response to Immune Therapy for Hepatocellular CarcinomaYongjie Zhou, Xin Zhou, Qingxin Liu, et al.
BMC Gastroenterology|April 11, 2025
Correlation and consistency analysis between various indirect portal pressure gradients and actual portal pressure gradientRufeng Chen, Yaozu Liu, Li Ma, et al.
Frontiers in Immunology|January 27, 2023
Microwave ablation and synchronous transarterial chemoembolization combined with PD-1 inhibitor in patients with hepatocellular carcinoma following tyrosine kinase inhibitor intoleranceQin Shi, Xin Zhou, Zihan Zhang, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|March 22, 2022
A new alternative technique for the guidance of transjugular intrahepatic portosystemic shunt creation using DSA overlay referenceZhiquan Zhuang, Jingqin Ma, Shuai Ju, et al.
Abdominal Radiology (New York)|June 20, 2024
Unveiling the impact of cirrhotic cardiomyopathy on portal hemodynamics and survival after transjugular intrahepatic portosystemic shunt: a prospective studyYaozu Liu, Fangmin Meng, Jingqin Ma, et al.
Journal of Cancer Research and Clinical Oncology|December 31, 2013
Transarterial chemoembolisation (TACE) combined with endovascular implantation of an iodine-125 seed strand for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis versus TACE alone: a two-arm, randomised clinical trialMinjie Yang, Zhuting Fang, Zhiping Yan, et al.
Pageof 21